LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Novel Device Yields Close-Up Look at Metastasis

By LabMedica International staff writers
Posted on 16 Nov 2014
Image: The Nikon Eclipse TE2000-U Inverted Fluorescence Microscope (Photo courtesy of Carmet Scientific).
Image: The Nikon Eclipse TE2000-U Inverted Fluorescence Microscope (Photo courtesy of Carmet Scientific).
A laboratory device has been invented that gives an unprecedented microscopic look at metastasis, the complex way that tumor cells spread through the body, causing more than 90% of cancer-related deaths.

One difficulty in studying metastasis stems from the complexity of the interface between the tumor microenvironment and the vascular system, but the newly developed investigational platform positions tumor cells next to an artificial vessel embedded in an extracellular matrix (ECM).

Scientists at Johns Hopkins University (Baltimore, MD, USA) used live-cell fluorescence microscopy to analyze the complex interplay between metastatic cancer cells and a functional artificial microvessel that was lined with endothelial cells. The ECM/vessel platform is composed of a cylindrical collagen channel located within a polydimethylsiloxane (PDMS) housing that is perfused by a gravity flow system.

Time-lapse, phase-contrast, and fluorescence images were captured using automated image acquisition software with a TE-2000 U microscope (Nikon; Tokyo, Japan). A 10× objective was used for all epifluorescence and phase-contrast imaging. Permeability was measured through quantitative fluorescence detection of molecular transport from inside the vessel to the surrounding ECM. A nutrient-rich solution flows through the artificial vessel, mimicking the properties of blood. The breast cancer cells, inserted individually and in clusters in the tissue near the vessel, are labeled with fluorescent tags, enabling their behavior to be seen, tracked and recorded via a microscopic viewing system.

The investigators were able to record video of the movement of individual cancer cells as they crawled through a three-dimensional collagen matrix. This material resembles the human tissue that surrounds tumors when cancer cells break away and try to relocate elsewhere in the body. This process is called invasion. They were able video single cancer cells prying and pushing their way through the wall of an artificial vessel lined with human endothelial cells, the same kind that line human blood vessels. By entering the bloodstream through this process, called intravasion, cancer cells are able to hitch a ride to other parts of the body and begin to form deadly new tumors.

Peter C. Searson, a professor and senior author of the study said, “We were able to build a functional artificial blood vessel and a microenvironment that lets us capture the details of the metastatic process. In the past it's been virtually impossible to see the steps involved in this process with this level of clarity. We've taken a significant leap forward.” The study was published on September 1, 2014, in the journal Cancer Research.

Related Links:

Johns Hopkins University 
Nikon 



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Hemodynamic System Monitor
OptoMonitor

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more